5:46 PM
Apr 02, 2014
 |  BC Extra  |  Clinical News

Allegro says BronchoGen improves lung cancer diagnosis

Allegro Diagnostics Inc. (Maynard, Mass.) said its BronchoGen genomic test used in conjunction with bronchoscopy met the primary endpoint of improved accuracy of lung cancer diagnosis vs. bronchoscopy alone in the pivotal AEGIS II trial. The trial enrolled...

Read the full 173 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >